Collectively, we showed that the suppression of the IL-22-STAT3-IGFBP5 axis is a key contributor to impaired endometrial receptivity in PCOS, providing a potential therapeutic target for improving pregnancy outcomes via IGFBP5 supplementation. The gene discussed is STAT3; the disease is polycystic ovary syndrome.